Literature DB >> 19818689

Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective?

Davide Pareyson, Alessandra Solari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19818689     DOI： 10.1016/S1474-4422(09)70270-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

1.  Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X.

Authors:  Janos Groh; Joachim Weis; Hanna Zieger; E Richard Stanley; Heike Heuer; Rudolf Martini
Journal:  Brain       Date:  2011-11-16       Impact factor: 13.501

2.  Inherited neuropathies.

Authors:  Angelo Schenone; Lucilla Nobbio; Margherita Monti Bragadin; Giulia Ursino; Marina Grandis
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

3.  Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.

Authors:  Davide Pareyson; Mary M Reilly; Angelo Schenone; Gian Maria Fabrizi; Tiziana Cavallaro; Lucio Santoro; Giuseppe Vita; Aldo Quattrone; Luca Padua; Franco Gemignani; Francesco Visioli; Matilde Laurà; Davide Radice; Daniela Calabrese; Richard A C Hughes; Alessandra Solari
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

4.  Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations.

Authors:  F Visioli; M M Reilly; M Rimoldi; A Solari; D Pareyson
Journal:  PharmaNutrition       Date:  2013-01

5.  Long-term outcome of Miniature Schnauzers with genetically confirmed demyelinating polyneuropathy: 12 cases.

Authors:  Alba Farré Mariné; Nicolas Granger; Coralie Bertolani; Joan Mascort Boixeda; G Diane Shelton; Alejandro Luján Feliu-Pascual
Journal:  J Vet Intern Med       Date:  2020-08-01       Impact factor: 3.333

6.  Effective therapeutic strategies in a preclinical mouse model of Charcot-Marie-Tooth disease.

Authors:  Cristina Nuevo-Tapioles; Fulvio Santacatterina; Brenda Sánchez-Garrido; Cristina Núñez de Arenas; Adrián Robledo-Bérgamo; Paula Martínez-Valero; Lara Cantarero; Beatriz Pardo; Janet Hoenicka; Michael P Murphy; Jorgina Satrústegui; Francesc Palau; José M Cuezva
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 6.150
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.